[High dose gestagen therapy following primary radiation therapy of endometrial carcinoma (author's transl)].
By a high dose gestagen therapy following primary radiation therapy of endometrial carcinoma it was possible to reduce the recurrence-rate 12 months after therapy in comparison with a control-group without gestagen therapy by more than 50%. Therefore this method is recommended not only for treatment of far advanced carcinoma of the endometrium but also as prophylactic therapy in cases of early endometrium cancer.
D004107:Dilatation and Curettage; D005260:Female; D006801:Humans; D008234:Lynestrenol / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D014594:Uterine Neoplasms / Q000532:radiotherapy*
D008234:Lynestrenol
Hormonprophylaxe bei der Strahlenbehandlung des Korpuskarzinoms mit hochdosierten Gestagenen.